Saturday 17 October 2026
Export TNDM’s income statement to Excel — free account
Tandem Diabetes Care, Inc.
TNDM Healthcare Medical Devices
Tandem Diabetes Care, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.0 billion, up 7.93% from fiscal 2024. In the quarter to June 2026, revenue grew 5.77%, EPS grew 60.3%, free cash flow fell 146.3% and total debt rose 94.9%, each against the same quarter a year earlier.
16.17
0.35
−2.12%
Follow TNDM
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 627.17 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
3 | 5 | 2 | 3 | 7 | 4 | 5 | 5 | 4 | 2 |
P/S ratio |
1.46 | 2.51 | 2.46 | 3.57 | 13.49 | 11.70 | 9.63 | 9.94 | 0.13 | 0.76 |
Altman Z-Score |
0.19 | 1.72 | 1.08 | 3.10 | 12.83 | 10.27 | 14.87 | 11.43 | (7.65) | (5.60) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 380.50 | 107.95 | 0.00 | 156.46 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(3.04) | (0.59) | (0.58) | 2.17 | 3.77 | 2.91 | (1.47) | (5.23) | (19.08) | (12.92) |
Beneish M-Score |
(3.10) | (2.87) | (3.52) | (2.38) | (2.58) | (2.46) | 0.29 | (4.65) | 0.14 | (3.79) |
P/Operating CF |
151.08 | 219.98 | (255.07) | 491.12 | 482.95 | 382.98 | 179.38 | 129.30 | (1.24) | (4.73) |
P/B ratio |
9.53 | 8.96 | 5.87 | 6.50 | 21.89 | 15.93 | 17.89 | 13.92 | 0.00 | 0.00 |
Price to Tangible BV |
9.59 | 8.99 | 5.89 | 6.51 | 21.94 | 15.97 | 17.97 | 14.04 | 0.00 | 0.00 |
EV/Sales |
1.47 | 2.37 | 2.22 | 3.15 | 13.01 | 11.13 | 9.18 | 9.66 | 0.71 | 1.04 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 236.86 | 491.73 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(153.92) | 91.95 | (52.11) | 50.03 | 82.08 | 225.12 | 79.35 | (213.43) | (1.16) | (1.43) |
EV/FCF |
(15.13) | (34.69) | (19.87) | 336.09 | 104.05 | (728.34) | 149.17 | (156.04) | (1.07) | (1.25) |
Quick Ratio |
1.89 | 2.24 | 2.94 | 4.43 | 5.57 | 5.46 | 2.24 | 2.48 | 0.97 | 2.12 |
Current Ratio |
2.55 | 2.93 | 3.83 | 5.14 | 6.15 | 6.14 | 2.78 | 2.83 | 1.78 | 2.93 |
Net Debt/EBITDA |
(0.10) | 1.57 | 0.86 | 4.61 | (8.87) | (24.96) | 14.49 | 3.53 | (1.11) | (0.32) |
Debt/Assets |
35.19% | 31.86% | 29.92% | 26.90% | 31.10% | 28.33% | 4.29% | 0.00% | 80.28% | 70.25% |
Debt/Equity |
2.00 | 1.17 | 0.91 | 0.64 | 0.65 | 0.55 | 0.07 | 0.00 | (2.63) | (13.32) |
Asset Turnover |
1.10 | 0.98 | 0.75 | 0.82 | 0.87 | 0.96 | 1.36 | 1.22 | 1.04 | 0.71 |
Operating CF/Net income |
0.05 | (0.25) | 0.14 | (0.53) | 7.15 | (0.72) | (1.69) | 0.07 | 0.91 | 0.73 |
Capex/Depreciation |
(1.27) | (4.01) | (2.40) | (2.10) | (1.48) | (1.68) | (3.55) | (0.37) | (0.83) | (1.65) |
Interest Coverage |
(23.68) | (13.37) | (23.60) | (14.96) | 3.75 | (0.62) | (5.11) | (5.90) | (5.55) | (13.68) |
| (97.88%) | (33.30%) | (59.08%) | (21.67%) | 3.89% | (12.25%) | (15.17%) | (240.11%) | 416.44% | (290.04%) | |
| (22.15%) | (10.00%) | (22.20%) | (9.66%) | 1.92% | (6.60%) | (9.30%) | (81.30%) | (70.31%) | (70.38%) | |
ROIC |
(67.83%) | (46.57%) | (111.48%) | (54.60%) | 15.60% | (5.90%) | (32.14%) | (1,240.85%) | (118.44%) | (278.83%) |
Return on Tangible Assets |
(44.60%) | (17.28%) | (35.38%) | (12.56%) | 2.13% | (5.89%) | (11.81%) | (88.37%) | (153.10%) | (105.60%) |
Average Days of Receivables |
59.53 | 44.48 | 51.53 | 52.26 | 57.51 | 60.14 | 46.93 | 69.86 | 70.53 | 48.40 |
Research and Development Expense of Revenue |
26.44% | 21.15% | 33.22% | 21.24% | 13.10% | 12.74% | 12.48% | 15.90% | 19.20% | 22.33% |
Selling, General and Administrative Expense of Revenue |
43.85% | 41.46% | 47.14% | 41.90% | 37.21% | 41.08% | 45.74% | 57.23% | 80.28% | 98.32% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 |
Share Based Compensation of Revenue |
9.10% | 10.78% | 11.78% | 10.60% | 8.64% | 11.71% | 16.03% | 12.91% | 11.74% | 13.84% |
Graham Net Nets |
(0.07) | 0.01 | 0.06 | 0.08 | 0.04 | 0.05 | 0.04 | 0.06 | (4.18) | (0.41) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 6.09 | 0.00 | 0.00 | 0.00 | 43.29 | 34.51 |
Earnings Yield |
(13.97%) | (4.05%) | (12.14%) | (3.30%) | 0.16% | (0.61%) | (0.74%) | (9.35%) | (638.58%) | (130.00%) |
Free Cash Flow Yield |
(6.69%) | (2.72%) | (4.53%) | 0.26% | 0.93% | (0.13%) | 0.64% | (0.62%) | (498.82%) | (109.32%) |
Revenue per Share |
15.08 | 14.37 | 11.51 | 12.49 | 11.16 | 8.18 | 6.19 | 3.82 | 18.95 | 27.56 |
Operating CF per Share |
(0.14) | 0.37 | (0.49) | 0.79 | 1.77 | 0.40 | 0.72 | (0.17) | (11.65) | (20.01) |
Capex per Share |
(0.30) | (1.00) | (0.79) | (0.67) | (0.37) | (0.53) | (0.33) | (0.06) | (1.01) | (2.92) |
Free Cash Flow per Share |
(0.44) | (0.63) | (1.28) | 0.12 | 1.39 | (0.12) | 0.38 | (0.23) | (12.66) | (22.93) |
Cash per Share |
4.35 | 6.70 | 7.20 | 9.62 | 9.90 | 7.95 | 3.02 | 2.68 | 2.50 | 18.17 |
Shareholders Equity per Share |
2.31 | 4.02 | 4.83 | 6.86 | 6.87 | 6.01 | 3.33 | 2.73 | (5.13) | (1.94) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.31 | 4.02 | 4.83 | 6.86 | 6.87 | 6.01 | 3.33 | 2.73 | (5.13) | (1.94) |
Free Cash Flow |
(29.67) | (41.41) | (83.41) | 7.51 | 87.85 | (7.62) | 22.37 | (11.30) | (71.85) | (70.10) |
Working Capital |
375.42 | 477.44 | 552.73 | 684.69 | 679.66 | 533.38 | 176.75 | 121.60 | 28.07 | 60.62 |
Capital Expenditures |
(19.95) | (65.63) | (51.60) | (42.95) | (23.51) | (32.29) | (19.54) | (2.99) | (5.72) | (8.93) |
Net Current Asset Value |
(107.80) | 19.93 | 108.96 | 237.14 | 339.50 | 287.13 | 145.01 | 112.87 | (60.34) | (26.23) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 403.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.07 | 0.07 | 0.05 | 0.03 | 0.06 | 0.05 | 0.02 | 0.05 | 0.11 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 418.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.19 | 0.21 | 0.28 | 0.30 | 0.32 | 0.38 | 0.17 | 0.47 | 0.35 | 0.29 |
Cash ROIC |
(3.91%) | (4.10%) | (7.82%) | 0.56% | 6.56% | (0.72%) | 5.80% | (4.34%) | (116.70%) | (54.52%) |
Accounts Receivable Turnover |
7.25 | 8.54 | 6.79 | 7.11 | 7.29 | 7.75 | 8.86 | 6.57 | 6.73 | 6.68 |
Accounts Payable Turnover |
10.21 | 9.56 | 7.22 | 9.27 | 14.25 | 13.41 | 13.68 | 15.71 | 10.03 | 9.52 |
Inventory Turnover |
3.37 | 2.93 | 2.82 | 4.32 | 4.94 | 4.23 | 4.87 | 4.01 | 2.64 | 3.13 |
Average Days of Payables |
36.65 | 36.23 | 47.63 | 52.40 | 31.33 | 27.27 | 38.53 | 26.49 | 29.60 | 45.21 |
Days of Inventory on Hand |
100.27 | 121.18 | 151.69 | 104.47 | 76.61 | 97.60 | 106.56 | 77.22 | 155.14 | 127.54 |
Average Receivables |
140.04 | 110.07 | 110.14 | 112.72 | 96.46 | 64.39 | 40.89 | 27.99 | 15.98 | 12.61 |
Average Payables |
45.90 | 47.16 | 52.66 | 41.88 | 22.92 | 17.78 | 12.28 | 5.99 | 6.33 | 6.37 |
Average Inventory |
139.19 | 153.77 | 134.53 | 89.83 | 66.14 | 56.40 | 34.48 | 23.44 | 24.09 | 19.37 |
Average Assets |
924.39 | 960.16 | 1,002.72 | 978.96 | 810.78 | 521.26 | 266.20 | 150.82 | 103.87 | 118.56 |
Average Common Equity |
209.13 | 288.37 | 376.79 | 436.53 | 399.71 | 280.64 | 163.13 | 51.06 | (17.54) | 28.77 |
Columns are period end dates